STAT Diagnostics said April 10 that it closed a Series C financing round totaling 25 million Euros ($28.5 million) led by Gilde Healthcare. Existing investors Kurma Partners; Ysios Capital; Idinvest Partners; Boehringer Ingelheim Venture Fund; Caixa Capital Risc; and Axis also participated. Barcelona-based STAT Diagnostics is a medical diagnostics company.